International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index; 5 of the 68 sources its claims cite were checked for support.
Abstract
In the accompanying comment letter (1), Weinert summarizes published data from the Brazilian Gestational Diabetes Study (2) and comments on applying International Association of Diabetes and Pregnancy Study Groups (IADPSG) Consensus Panel recommendations (3) for the diagnosis of gestational diabetes mellitus (GDM) to that cohort. The Brazilian study provided evidence that adverse perinatal outcomes are associated with levels of maternal glycemia below those diagnostic of GDM by American Diabetes Association or World Health Organization criteria. However, the results were potentially confounded by the treatment of GDM. It did find that women with GDM were at increased risk for some …
Overview
CoChat Summary
## TL;DR
This IADPSG consensus report recommends new gestational diabetes mellitus (GDM) diagnostic thresholds based on HAPO study data, using a 75-g OGTT and outcome-linked glucose cutoffs. It also recommends early detection of overt diabetes in pregnancy and notes that these recommendations will increase the frequency of diagnosed hyperglycemic disorders in pregnancy.
## Key findings
- In the HAPO study, a 75-g OGTT was performed in a heterogeneous, multinational, multicultural, ethnically diverse cohort of approximately 25,000 women in the third trimester; medical caregivers were blinded unless predefined glucose criteria were exceeded.
- The report states that the HAPO data showed continuous, graded associations between maternal glucose and primary outcomes, with no obvious thresholds; associations were also observed for secondary outcomes and did not differ among centers.
- The recommended diagnostic thresholds correspond to glucose levels where odds for birth weight >90th percentile, cord C-peptide >90th percentile, and percent body fat >90th percentile reached 1.75 times the estimated odds at mean glucose values; by these criteria, FPG alone identified 8.3% of the HAPO cohort, FPG plus 1-hour glucose identified an additional 5.7%, and 2-hour glucose another 2.1%, for a total GDM incidence of 17.8%.
- Among the HAPO cohort, 11.1% had only one elevated result, 3.9% had two elevated results, 1.1% had all three elevated, and 1.7% were unblinded because FPG or 2-hour glucose exceeded 5.8 mmol/l (105 mg/dl) or 11.1 mmol/l (200 mg/dl).
## Methods
- Consensus report based on review of the HAPO study, additional unpublished HAPO findings, and other published studies discussed at a June 2008 IADPSG workshop/meeting in Pasadena, followed by consensus panel deliberation.
- HAPO design described as observational: a 75-g OGTT in a large multinational cohort, with blinded caregivers except for preset safety thresholds.
- Thresholds were derived from fully adjusted logistic regression models relating continuous maternal glucose measures (FPG, 1-hour, 2-hour) to outcomes; the panel selected an odds ratio threshold of 1.75 relative to mean glucose values.
## Limitations
- The paper states that recommendations for detecting overt diabetes during pregnancy are based on the opinions of the IADPSG Consensus Panel because prospective studies or appropriately designed clinical trials were not available.
- It states that it was not determined whether universal early testing for overt diabetes is clinically valuable or cost-effective.
- Evident from the text: the HAPO study was observational, not a clinical trial, so the diagnostic thresholds are inferred from associations rather than randomized intervention effects.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
4 Valid · 0 Not valid · 36 Not checked · 22 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Similar associations were also observed for secondary outcomes (25,26).”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > THE HAPO STUDY
What the sources say
- Not checked yetcites [25] HAPO Study Cooperative Research Group Metzger BE Lowe LP Dyer AR Trimble ER Chaovarindr U Coustan DR Hadden DR McCance DR Hod M McIntyre HD Oats JJ Persson B Rogers MS Sacks DA: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991– 2002 18463375 source
- Supportedcites [26] HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009; 58: 453– 459 19011170 PMC2628620 source
The Abstract of our copy states that the predefined primary outcomes (size at birth, cesarean delivery, neonatal hypoglycemia, fetal hyperinsulinemia) were reported elsewhere, and that this report's goals were to examine maternal glycemia against additional/newborn anthropometric outcomes (sum of skin folds, individual skin folds, percent body fat) plus cord C-peptide. The Results report strong, graded, continuous associations for these outcomes (e.g., ORs 1.33–1.47 for percent body fat >90th percentile and 1.28–1.56 for individual skin folds), and the Discussion explicitly says 'This pattern is similar to that reported for maternal glucose and birth weight >90th percentile.' That covers the claim's substance — similar associations for the secondary/additional outcomes — even though the paper does not use the label 'secondary outcomes'. (LLM, conf=0.85)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Associations of LGA and excess adiposity with fetal hyperinsulinemia are strong and independent of confounders (26,37,38).”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > TRANSLATION OF HAPO STUDY RESULTS FOR DIAGNOSIS OF GDM
What the sources say
- Supportedcites [26] HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009; 58: 453– 459 19011170 PMC2628620 source
In the Results (Table 5), higher cord C-peptide, the paper’s measure of fetal insulin, is strongly associated with birth weight above the 90th percentile and adiposity measures. The Discussion states that the relationships persisted after adjustment for potential confounders. The paper does not claim that every possible confounder was excluded. (LLM, conf=0.92)
- Not checked yetcites [37] Metzger BE Silverman BL Freinkel N Dooley SL Ogata ES Green OC: Amniotic fluid insulin concentration as a predictor of obesity. Arch Dis Child 1990; 65: 1050– 1052 2241225 PMC1590256 source
- Not checked yetcites [38] Weiss PA Haeusler M Tamussino K Haas J: Can glucose tolerance test predict fetal hyperinsulinism? BJOG 2000; 107: 1480– 1485 11192103 source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Although not directly comparable, it was concluded that results of the two randomized controlled trials (47,48) and HAPO (25,26) are highly complementary.”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > TRANSLATION OF HAPO STUDY RESULTS FOR DIAGNOSIS OF GDM > Other considerations
What the sources say
- Supportedcites [47] Crowther CA Hiller JE Moss JR McPhee AJ Jeffries WS Robinson JS: Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352: 2477– 2486 15951574 source
The paper identifies itself as a randomized clinical trial and reports its treatment results (secondary outcomes; page unavailable). In the citing sentence, this citation identifies one of the two trials whose results are being discussed; it does not attribute the cross-study judgment of complementarity to this trial paper. (LLM, conf=0.88)
- Not checked yetcites [48] Landon MB Spong CY Thom E Carpenter MW Ramin SM Casey B Wapner RJ Varner MW Rouse DJ Thorp JM Jr Sciscione A Catalano P Harper M Saade G Lain KY Sorokin Y Peaceman AM Tolosa JE Anderson GB: Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009: 361; 1339– 1348. PMC2804874 19797280
- Not checked yetcites [25] HAPO Study Cooperative Research Group Metzger BE Lowe LP Dyer AR Trimble ER Chaovarindr U Coustan DR Hadden DR McCance DR Hod M McIntyre HD Oats JJ Persson B Rogers MS Sacks DA: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991– 2002 18463375 source
- Could not verifycites [26] HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009; 58: 453– 459 19011170 PMC2628620 sourceExperimental — accuracy not yet measured
The Abstract reports HAPO findings on maternal glucose and pregnancy outcomes, but does not compare them with randomized trials. Searches for randomized trials and for the claimed complementarity found no passage in our copy making that comparison. No page numbers were available. (LLM, conf=0.70)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
In the paper
“Importantly, there were continuous graded relationships between higher maternal glucose and increasing frequency of the primary outcomes, independent of other risk factors (25).”
- Also stated in: § Future considerations · boosted
“The HAPO study was a basic epidemiological investigation that for the first time conclusively identified strong continuous associations of maternal glucose levels below those diagnostic of diabetes with several perinatal outcomes.”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > THE HAPO STUDY
What the sources say
- Not checked yetcites [25] HAPO Study Cooperative Research Group Metzger BE Lowe LP Dyer AR Trimble ER Chaovarindr U Coustan DR Hadden DR McCance DR Hod M McIntyre HD Oats JJ Persson B Rogers MS Sacks DA: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991– 2002 18463375 source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Future considerations · boosted
None of the sources cited for this claim have been checked yet.
In the paper
“HAPO data show strong linear associations of risks for >90th percentiles of birth weight, cord C-peptide, and percent body fat with each of three measures of maternal glucose (FPG, 1-h, and 2-h post–75-g load).”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > TRANSLATION OF HAPO STUDY RESULTS FOR DIAGNOSIS OF GDM
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
40 more claims
Create a free account to see all 62 claims and to verify the 63 references still open.
- It may state two separate claims as one. 10
- Probably not a substantial claim. 8
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“GDM was identified when fasting blood glucose (FBG) ≥ 5.1 mmol/L during the first trimester or any plasma glucose after a 75 g OGTT performed as: FBG ≥ 5.1 mmol/L, 1 h after glucose load ≥ 10.0 mmol/L or 2 h after glucose load ≥ 8.5 mmol/L using the criteria of International Association of Diabetes and Pregnancy Study Groups (IADPSG) [28].”
From Associations of maternal pre-pregnancy BMI and gestational weight gain with the risks of adverse pregnancy outcomes in Chinese women with gestational diabetes mellitus (2023) · cites this paper as [28]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“to adopt diagnostic glucose thresholds corresponding to a HAPO OR of 1.75 (fasting plasma glucose [FPG] 5.1–6.9 mmol/L, one‐hour plasma glucose [1hPG] ≥ 10.0 mmol/L, and/or two‐hour plasma glucose [2hPG] 8.5–11.0 mmol/L). 14”
From Australasian Diabetes in Pregnancy Society ( ADIPS ) 2025 consensus recommendations for the screening, diagnosis and classification of gestational diabetes (2025) · cites this paper as [14]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The IADPSG diagnostic thresholds are the first criteria based on risks of adverse perinatal outcomes, rather than risk of subsequent development of maternal diabetes1 or by applying thresholds that define impaired glucose tolerance outside of pregnancy.5,6”
From Gestational Diabetes Mellitus (2019) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“following the diagnostic criteria proposed by the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) (18)”
From Diabetes gestacional y riesgo de apnea obstructiva del sueño en el tercer trimestre (2025) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“Based on the HAPO Study and other studies, new criteria for the diagnosis of gestational diabetes were proposed by the International Association of Diabetes and Pregnancy Study Groups (IADPSG) 2 and adopted by the World Health Organization and others.3,4”
From Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood Adiposity (2018) · cites this paper as [2]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Prevalence of Overweight and Obesity in the United States, 1999-2004
Ogden, C. L., Carroll, M. D., Curtin, L. R., McDowell, M. A., Tabak, C. J., & Flegal, K. M. (2006) · JAMA · doi:10.1001/jama.295.13.1549 · Cited by 8,720
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Boney, C. M., Verma, A., Tucker, R., & Vohr, B. R. (2005) · Pediatrics · doi:10.1542/peds.2004-1808 · Cited by 2,303 · cited 2×
“Long-term risks associated with fetal macrosomia in infants of women with GDM (independent of confounders) include childhood overweight (43,44) and metabolic factors that may increase risk of cardiovascular disease (CVD) (45).”
BackgroundA Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122
Metzger, B. E., Buchanan, T. A., Coustan, D. R., de Leiva, A., Dunger, D. B., Hadden, D. R., Hod, M., Kitzmiller, J. L., Kjos, S. L., Oats, J. N., et al. (2007) · Diabetes Care · doi:10.2337/dc07-s225 · Cited by 1,908
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s062 · Cited by 1,817
(1964) · PubMed · Cited by 1,230
(1998) · PubMed · Cited by 992
The Rising Prevalence of Diabetes and Impaired Glucose Tolerance
Dunstan, D. W., Zimmet, P. Z., Welborn, T. A., de Courten, M. P., Cameron, A. J., Sicree, R. A., Dwyer, T., Colagiuri, S., Jolley, D., Knuiman, M., et al. (2002) · Diabetes Care · doi:10.2337/diacare.25.5.829 · Cited by 907
Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study
The HAPO Study Cooperative Research Group (2009) · Diabetes · doi:10.2337/db08-1112 · Cited by 702
Gestational diabetes: The consequences of not treating
Langer, O., Yogev, Y., Most, O., & Xenakis, E. M. J. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.11.039 · Cited by 677 · cited 1×
“Fetal macrosomia (LGA) is a major indicator of the effects of hyperglycemia during pregnancy (12,35,36).”
BackgroundLawrence, J. M., Contreras, R., Chen, W., & Sacks, D. A. (2008) · Diabetes Care · doi:10.2337/dc07-2345 · Cited by 658
Childhood Obesity and Metabolic Imprinting
Hillier, T. A., Pedula, K. L., Schmidt, M. M., Mullen, J. A., Charles, M.-A., & Pettitt, D. J. (2007) · Diabetes Care · doi:10.2337/dc06-2361 · Cited by 656
Macrosomic births in the united states: Determinants, outcomes, and proposed grades of risk
Boulet, S. L., Alexander, G. R., Salihu, H. M., & Pass, M. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2003.302 · Cited by 587 · cited 1×
“Risks of difficult delivery and maternal/ neonatal damage associated with fetal macrosomia (9,40) were confirmed in large populations (41,42).”
BackgroundSermer, M., Naylor, C. D., Gare, D. J., Kenshole, A. B., Ritchie, J. W. K., Farine, D., Cohen, H. R., McArthur, K., Holzapfel, S., Biringer, A., et al. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)90183-3 · Cited by 510 · cited 1×
“The Toronto TriHospital Study showed continuous associations between maternal glycemia and adverse pregnancy outcomes (29).”
BackgroundEffect of BMI on Lifetime Risk for Diabetes in the U.S.
Narayan, K. M. V., Boyle, J. P., Thompson, T. J., Gregg, E. W., & Williamson, D. F. (2007) · Diabetes Care · doi:10.2337/dc06-2544 · Cited by 510
Metzger, B. E. (1991) · Diabetes · doi:10.2337/diab.40.2.s197 · Cited by 481 · cited 1×
“(16) found risk of severe macrosomia, neonatal hypoglycemia, and hyperbilirubinemia increased with increasing number of abnormal glucose values according to current American Diabetes Association cut points (2,5) among women who did not meet National Diabetes Data Group criteria for GDM (31).”
BackgroundMacrosomia--maternal characteristics and infant complications.
Spellacy, W. N., Miller, S., Winegar, A., & Peterson, P. Q. (1985) · PubMed · Cited by 403
The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study
HAPO Study Cooperative Research Group (2002) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(02)00092-9 · Cited by 401
How big is too big? The perinatal consequences of fetal macrosomia
Zhang, X., Decker, A., Platt, R. W., & Kramer, M. S. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.12.005 · Cited by 341 · cited 1×
“Risks of difficult delivery and maternal/ neonatal damage associated with fetal macrosomia (9,40) were confirmed in large populations (41,42).”
BackgroundConsensus Statement on the Worldwide Standardization of the Hemoglobin A1C Measurement
Consensus Committee (2007) · Diabetes Care · doi:10.2337/dc07-9925 · Cited by 303
U.S. Preventive Services Task Force* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-10-200805200-00008 · Cited by 291
Pettitt, D. J., Knowler, W. C., Baird, H. R., & Bennett, P. H. (1980) · Diabetes Care · doi:10.2337/diacare.3.3.458 · Cited by 278 · cited 1×
“(27) found that maternal plasma glucose concentration during pregnancy (measured 2 h after a 75-g load) had a continuous association with adverse pregnancy outcomes (LGA and cesarean section).”
BackgroundFirst-Trimester Fasting Hyperglycemia and Adverse Pregnancy Outcomes
Riskin-Mashiah, S., Younes, G., Damti, A., & Auslender, R. (2009) · Diabetes Care · doi:10.2337/dc09-0688 · Cited by 277
Esakoff, T. F., Cheng, Y. W., Sparks, T. N., & Caughey, A. B. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.02.035 · Cited by 264 · cited 1×
“Risks of difficult delivery and maternal/ neonatal damage associated with fetal macrosomia (9,40) were confirmed in large populations (41,42).”
Background(1998) · PubMed · Cited by 239
Birth Weight and Parental BMI Predict Overweight in Children From Mothers With Gestational Diabetes
Schaefer-Graf, U. M., Pawliczak, J., Passow, D., Hartmann, R., Rossi, R., Bührer, C., Harder, T., Plagemann, A., Vetter, K., & Kordonouri, O. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1745 · Cited by 219 · cited 1×
“Long-term risks associated with fetal macrosomia in infants of women with GDM (independent of confounders) include childhood overweight (43,44) and metabolic factors that may increase risk of cardiovascular disease (CVD) (45).”
BackgroundToward universal criteria for gestational diabetes: the 75-gram glucose tolerance test in pregnancy
Sacks, D. A., Greenspoon, J. S., Abu-Fadil, S., Henry, H. M., Wolde-Tsadik, G., & Yao, J. F. F. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)90580-4 · Cited by 210
Screening for gestational diabetes: a systematic review and economic evaluation
Scott, D. A., Loveman, E., McIntyre, L., & Waugh, N. (2002) · Health Technology Assessment · doi:10.3310/hta6110 · Cited by 203
The significance of one abnormal glucose tolerance test value on adverse outcome in pregnancy
Langer, O., Brustman, L., Anyaegbunam, A., & Mazze, R. (1987) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(87)80045-5 · Cited by 200
Congenital malformations in offspring of women with hyperglycemia first detected during pregnancy
Schaefer, U. M., Songster, G., Xiang, A., Berkowitz, K., Buchanan, T. A., & Kjos, S. L. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70035-8 · Cited by 195 · cited 1×
“● Increased risk of congenital anomalies in offspring (51).”
BackgroundWomen With Impaired Glucose Tolerance During Pregnancy Have Significantly Poor Pregnancy Outcomes
Yang, X., Hsu-Hage, B., Zhang, H., Zhang, C., Zhang, Y., & Zhang, C. (2002) · Diabetes Care · doi:10.2337/diacare.25.9.1619 · Cited by 180 · cited 1×
“Fetal macrosomia (LGA) is a major indicator of the effects of hyperglycemia during pregnancy (12,35,36).”
BackgroundGestational diabetes mellitus diagnosed during early pregnancy
Bartha, J. L., Martinez-Del-Fresno, P., & Comino-Delgado, R. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(00)70222-5 · Cited by 172 · cited 1×
“● Need for rapid treatment and close follow-up during pregnancy to ensure prompt restoration of normal glycemia (53,54).”
BackgroundEffects of maternal gestational diabetes on offspring adiposity at 4-7 years of age
Vohr, B. R., McGarvey, S. T., & Tucker, R. (1999) · Diabetes Care · doi:10.2337/diacare.22.8.1284 · Cited by 166
Jensen, D. M., Damm, P., Sørensen, B., Mølsted-Pedersen, L., Westergaard, J. G., Klebe, J., & Beck-Nielsen, H. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.115864 · Cited by 160 · cited 1×
“Another analysis of that cohort (11) showed a linear relationship between maternal fasting glucose and macrosomia.”
BackgroundFerrara, A. M., Weiss, N. S., Hedderson, M. M., Quesenberry, C. P., Selby, J. V., Ergas, I. J., Peng, T., Escobar, G. J., Pettitt, D. J., & Sacks, D. A. (2006) · Diabetologia · doi:10.1007/s00125-006-0517-8 · Cited by 155 · cited 1×
“(16) found risk of severe macrosomia, neonatal hypoglycemia, and hyperbilirubinemia increased with increasing number of abnormal glucose values according to current American Diabetes Association cut points (2,5) among women who did not meet National Diabetes Data Group criteria for GDM (31).”
BackgroundVambergue, A., Nuttens, M. C., Verier‐Mine, O., Dognin, C., Cappoen, J. P., & Fontaine, P. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00237.x · Cited by 101
JENSEN, D. M., Korsholm, L., Ovesen, P., Beck‐Nielsen, H., Mølsted‐Pedersen, L., & Damm, P. (2007) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1080/00016340701823975 · Cited by 94 · cited 1×
“A Danish study of pregnant women with mild glucose intolerance but without GDM found a linear association between maternal 2-h glucose and cesarean delivery, spontaneous preterm delivery, shoulder dystocia, and macrosomia after adjustment for confounders (28).”
BackgroundAmniotic fluid insulin concentration as a predictor of obesity.
Metzger, B. E., Silverman, B. L., Freinkel, N., Dooley, S. L., Ogata, E. S., & Green, O. C. (1990) · Archives of Disease in Childhood · doi:10.1136/adc.65.10_spec_no.1050 · Cited by 90 · cited 1×
“Associations of LGA and excess adiposity with fetal hyperinsulinemia are strong and independent of confounders (26,37,38).”
BackgroundHAPO Study Cooperative Research Group, Nesbitt, G. S., Smye, M., Sheridan, B., Lappin, T. R., & Trimble, E. R. (2006) · Clinical Trials · doi:10.1177/1740774506070695 · Cited by 87
Jang, H. C., Cho, N. H., Min, Y.-K., Han, I. K., Jung, K. B., & Metzger, B. E. (1997) · Diabetes Care · doi:10.2337/diacare.20.10.1582 · Cited by 86 · cited 1×
“Fetal macrosomia (LGA) is a major indicator of the effects of hyperglycemia during pregnancy (12,35,36).”
BackgroundScreening tests for gestational diabetes in Japan in the 1st and 2nd trimester of pregnancy
Maegawa, Y., Sugiyama, T., Kusaka, H., Mitao, M., & Toyoda, N. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(03)00146-3 · Cited by 85 · cited 1×
“● Need for rapid treatment and close follow-up during pregnancy to ensure prompt restoration of normal glycemia (53,54).”
BackgroundSacks, D. A., Abu-Fadil, S., Greenspoon, J. S., & Fotheringham, N. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(89)90369-4 · Cited by 82
Feig, D. S., Razzaq, A., Sykora, K., Hux, J. E., & Anderson, G. M. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1482 · Cited by 80
REFLECTIONS ON GESTATIONAL DIABETES MELLITUS
Jarrett, R. J. (1981) · The Lancet · doi:10.1016/s0140-6736(81)91451-3 · Cited by 69
Effects of Hyperinsulinemia in the Primate Fetus
Susa, J. B., & Schwartz, R. (1985) · Diabetes · doi:10.2337/diab.34.2.s36 · Cited by 58 · cited 1×
“This is supported by experiments in pregnant monkeys (39).”
ResultComparison of international and New Zealand guidelines for the care of pregnant women with diabetes
Cutchie, W. A., Cheung, N. W., & Simmons, D. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01850.x · Cited by 55 · cited 1×
“The initial criteria for its diagnosis were established more than 40 years ago (3) and, with modifications (4), remain in use today.”
BackgroundProposal for the reconsideration of the definition of gestational diabetes
Omori, Y., & Jovanovic, L. (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2592 · Cited by 54 · cited 1×
“● Risk of diabetes complications (nephropathy and retinopathy) requiring treatment during pregnancy (52).”
BackgroundStahl, M., Brandslund, I., Jørgensen, L. G. M., Petersen, P. H., Borch-Johnsen, K., & Olivarius, N. D. F. (2002) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/003655102753611799 · Cited by 50
Management of Gestational Diabetes Mellitus: A Self-fulfilling Prophecy?
Coustan, D. R. (1996) · JAMA · doi:10.1001/jama.1996.03530390065037 · Cited by 46
Can glucose tolerance test predict fetal hyperinsulinism?
Weiss, P., Haeusler, M. C. H., Tamussino, K. F., & Haas, J. G. (2000) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2000.tb11671.x · Cited by 33 · cited 1×
“Associations of LGA and excess adiposity with fetal hyperinsulinemia are strong and independent of confounders (26,37,38).”
BackgroundJayaweera, H., Joshi, H. E., Macfarlane, A., Hawkes, D. D., & Butler, N. R. (2005) · doi:10.46692/9781847421418.004 · Cited by 4
(1980) · PubMed
Research works printed but not linked: 2
- Canadian Task Force on the Periodic Health Examination. The Canadian guide to clinical preventive health care. Health Canada 1994; 15– 23
- National Collaborating Centre for Women's and Children's Health. Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal Period. London, U.K., RCOG Press, 2008 21370515
Cited by
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
“Current screening and diagnostic strategies, based on the IADPSG statement (12), are outlined in Table 4.”
MethodStandards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
Standards of medical care in diabetes—2011
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s011 · Cited by 2,880
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s067 · Cited by 2,245
“Current screening and diagnostic strategies, based on the IADPSG statement (14), are outlined in Table 4.”
MethodStandards of Medical Care in Diabetes—2012
(2012) · Diabetes Care · doi:10.2337/dc12-s011 · Cited by 2,240
“Current screening and diagnostic strategies, based on the IADPSG statement (33), are outlined in Table 6.”
Method
Metadata
- Authors
- International Association of Diabetes and Pregnancy Study Groups Consensus Panel
- Corresponding author
- International Association of Diabetes and Pregnancy Study Groups Consensus Panel
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-03-01
- Volume
- 33
- Issue
- 3
- Pages
- 676-682
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2827530
- OpenAlex
- W2616235706
- Cited by
- 5,390
- References
- 56
- Citations by year
- 2026: 314 · 2025: 377 · 2024: 446 · 2023: 423 · 2022: 494 · 2021: 507 · 2020: 425 · 2019: 350 · 2018: 367 · 2017: 297 · 2016: 274 · 2015: 296 · 2014: 235 · 2013: 203 · 2012: 167
- FWCI
- 250.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- American Diabetes Association
- Kaiser Permanente
- National Institute of Child Health and Human Development (R01‐HD34242, R01-HD-34243)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01-HD-34243, R01-HD-34242, R01HD034242, R01HD034243)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- gestational diabetes mellitus, hyperglycemia in pregnancy, IADPSG criteria, perinatal outcomes, maternal glycemia, diagnostic thresholds
- MeSH terms
- Female, Health Planning Guidelines, Humans, Hyperglycemia, International Cooperation, Pregnancy, Pregnancy Complications, Pregnancy in Diabetics, Societies, Medical, Diabetes, Gestational, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.